T-Cells

New anticancer drugs could significantly improve immunotherapy

EZH2 inhibitors significantly enhance lymphoma immunotherapies, improving CAR-T and antibody therapy outcomes in preclinical studies.

Breakthrough immunotherapy drug revolutionizes pancreatic cancer treatment Joshua Shavit